Cancer vaccines: why BioNTech is banking on the UK

29 January 202329 January 2023

Reserved for subscribers

The German laboratory will set up its new research center across the Channel and conduct clinical trials of a messenger RNA cancer vaccine.

From our correspondent in London, Laure Van Ruymbeke,

The founders of BioNTech, Ugur Sahin and Özelem Türeci, have signed an agreement with the British government to set up a research and development center.
© ARNE DEDERT / DPA / dpa Picture-Alliance via AFP

Published on 01/29/2023 at 07:30

Subscriber-only audio playback

I subscribe to 1€ the 1st month

Source link -82